{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:15:46Z","timestamp":1783386946052,"version":"3.54.6"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51967-0","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:38:38Z","timestamp":1778125118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Yan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Song","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Shuang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"51967_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345. https:\/\/doi.org\/10.3322\/caac.21871 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"51967_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia, C. et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin. Med. J. (Engl). 135, 584\u2013590. https:\/\/doi.org\/10.1097\/CM9.0000000000002108 (2022).","journal-title":"Chin. Med. J. (Engl)"},{"key":"51967_CR3","doi-asserted-by":"publisher","first-page":"16425","DOI":"10.1038\/s41598-020-73525-y","volume":"10","author":"A Bengtsson","year":"2020","unstructured":"Bengtsson, A., Andersson, R. & Ansari, D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data. Sci. Rep. 10, 16425. https:\/\/doi.org\/10.1038\/s41598-020-73525-y (2020).","journal-title":"Sci. Rep."},{"key":"51967_CR4","doi-asserted-by":"publisher","first-page":"615684","DOI":"10.3389\/fnut.2020.615684","volume":"7","author":"KA Della Corte","year":"2020","unstructured":"Della Corte, K. A. et al. The prospective association of dietary sugar intake in adolescence with risk markers of type 2 diabetes in young adulthood. Front. Nutr. 7, 615684. https:\/\/doi.org\/10.3389\/fnut.2020.615684 (2020).","journal-title":"Front. Nutr."},{"key":"51967_CR5","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155 (2014).","journal-title":"Cancer Res."},{"key":"51967_CR6","doi-asserted-by":"publisher","unstructured":"Farhangnia, P., Khorramdelazad, H., Nickho, H. & Delbandi, A. A. Current and future immunotherapeutic approaches in pancreatic cancer treatment. J. Hematol. Oncol. https:\/\/doi.org\/10.1186\/s13045-024-01561-6 (2024).","DOI":"10.1186\/s13045-024-01561-6"},{"key":"51967_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos, J. P. et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat. Rev. Gastroenterol. Hepatol. 15, 333\u2013348. https:\/\/doi.org\/10.1038\/s41575-018-0005-x (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"51967_CR8","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.mito.2024.101977","volume":"80","author":"R Keerthiga","year":"2025","unstructured":"Keerthiga, R., Xie, Y., Pei, D. S. & Fu, A. The multifaceted modulation of mitochondrial metabolism in tumorigenesis. Mitochondrion 80, 101977. https:\/\/doi.org\/10.1016\/j.mito.2024.101977 (2025).","journal-title":"Mitochondrion"},{"key":"51967_CR9","doi-asserted-by":"publisher","first-page":"e2403520","DOI":"10.1002\/advs.202403520","volume":"11","author":"Y Li","year":"2024","unstructured":"Li, Y., Liu, J., Weichselbaum, R. R. & Lin, W. Mitochondria-targeted multifunctional nanoparticles combine cuproptosis and programmed cell death-1 downregulation for cancer immunotherapy. Adv. Sci. (Weinh). 11, e2403520. https:\/\/doi.org\/10.1002\/advs.202403520 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"51967_CR10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7150\/ijbs.81609","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. An overview: the diversified role of mitochondria in cancer metabolism. Int. J. Biol. Sci. 19, 897\u2013915. https:\/\/doi.org\/10.7150\/ijbs.81609 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"51967_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong, Y. et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal. Transduct. Target. Ther. 9, 124. https:\/\/doi.org\/10.1038\/s41392-024-01839-8 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"51967_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2025.12.002","author":"L Minarrieta","year":"2026","unstructured":"Minarrieta, L. & St-Pierre, J. Rethinking mitochondria as a target for cancer therapy. Trends Mol. Med. https:\/\/doi.org\/10.1016\/j.molmed.2025.12.002 (2026).","journal-title":"Trends Mol. Med."},{"key":"51967_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","volume":"10","author":"H Du","year":"2025","unstructured":"Du, H., Xu, T., Yu, S., Wu, S. & Zhang, J. Mitochondrial metabolism and cancer therapeutic innovation. Signal. Transduct. Target. Ther. 10, 245. https:\/\/doi.org\/10.1038\/s41392-025-02311-x (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"51967_CR14","doi-asserted-by":"publisher","first-page":"107382","DOI":"10.1016\/j.phrs.2024.107382","volume":"208","author":"V Marabitti","year":"2024","unstructured":"Marabitti, V., Vulpis, E., Nazio, F. & Campello, S. Mitochondrial transfer as a strategy for enhancing cancer cell fitness:current insights and future directions. Pharmacol. Res. 208, 107382. https:\/\/doi.org\/10.1016\/j.phrs.2024.107382 (2024).","journal-title":"Pharmacol. Res."},{"key":"51967_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G. & Galluzzi, L. Mitochondrial metabolism and cancer. Cell. Res. 28, 265\u2013280. https:\/\/doi.org\/10.1038\/cr.2017.155 (2018).","journal-title":"Cell. Res."},{"key":"51967_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan, K., Werner, M. & Chandel, N. S. Mitochondrial metabolism as a target for cancer therapy. Cell. Metab. 32, 341\u2013352. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.019 (2020).","journal-title":"Cell. Metab."},{"key":"51967_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12943-024-02175-9","volume":"23","author":"MQ Yang","year":"2024","unstructured":"Yang, M. Q. et al. Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells. Mol. Cancer. 23, 260. https:\/\/doi.org\/10.1186\/s12943-024-02175-9 (2024).","journal-title":"Mol. Cancer"},{"key":"51967_CR18","doi-asserted-by":"publisher","first-page":"1453886","DOI":"10.3389\/fimmu.2024.1453886","volume":"15","author":"M Ahn","year":"2024","unstructured":"Ahn, M., Ali, A. & Seo, J. H. Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy. Front. Immunol. 15, 1453886. https:\/\/doi.org\/10.3389\/fimmu.2024.1453886 (2024).","journal-title":"Front. Immunol."},{"key":"51967_CR19","doi-asserted-by":"publisher","first-page":"1448764","DOI":"10.3389\/fimmu.2024.1448764","volume":"15","author":"G Gao","year":"2024","unstructured":"Gao, G., Miao, J., Jia, Y. & He, A. Mitochondria-associated programmed cell death: elucidating prognostic biomarkers, immune checkpoints, and therapeutic avenues in multiple myeloma. Front. Immunol. 15, 1448764. https:\/\/doi.org\/10.3389\/fimmu.2024.1448764 (2024).","journal-title":"Front. Immunol."},{"key":"51967_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41416-024-02817-1","volume":"131","author":"MJ Berner","year":"2024","unstructured":"Berner, M. J., Wall, S. W. & Echeverria, G. V. Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities. Br. J. Cancer. 131, 1415\u20131424. https:\/\/doi.org\/10.1038\/s41416-024-02817-1 (2024).","journal-title":"Br. J. Cancer"},{"key":"51967_CR21","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int. J. Surg. 107, 106936. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936 (2022).","journal-title":"Int. J. Surg."},{"key":"51967_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.191.4.651","volume":"191","author":"PJ Blair","year":"2000","unstructured":"Blair, P. J. et al. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191, 651\u2013660. https:\/\/doi.org\/10.1084\/jem.191.4.651 (2000).","journal-title":"J. Exp. Med."},{"key":"51967_CR23","doi-asserted-by":"publisher","unstructured":"Laubach, V., Kaufmann, R., Bernd, A., Kippenberger, S. & Zoller, N. Extrinsic or intrinsic apoptosis by curcumin and light: still a mystery. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20040905 (2019).","DOI":"10.3390\/ijms20040905"},{"key":"51967_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-022-01260-0","volume":"15","author":"M Liao","year":"2022","unstructured":"Liao, M. et al. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies. J. Hematol. Oncol. 15, 44. https:\/\/doi.org\/10.1186\/s13045-022-01260-0 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"51967_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal. Transduct. Target. Ther. 7, 286. https:\/\/doi.org\/10.1038\/s41392-022-01110-y (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"51967_CR26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"E Vringer","year":"2023","unstructured":"Vringer, E. & Tait, S. W. G. Mitochondria and cell death-associated inflammation. Cell. Death Differ. 30, 304\u2013312. https:\/\/doi.org\/10.1038\/s41418-022-01094-w (2023).","journal-title":"Cell. Death Differ."},{"key":"51967_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1042\/BST20200522","volume":"49","author":"S Dadsena","year":"2021","unstructured":"Dadsena, S., Zollo, C. & Garcia-Saez, A. J. Mechanisms of mitochondrial cell death. Biochem. Soc. Trans. 49, 663\u2013674. https:\/\/doi.org\/10.1042\/BST20200522 (2021).","journal-title":"Biochem. Soc. Trans."},{"key":"51967_CR28","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","volume":"55","author":"TT Nguyen","year":"2023","unstructured":"Nguyen, T. T. et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp. Mol. Med. 55, 1595\u20131619. https:\/\/doi.org\/10.1038\/s12276-023-01046-5 (2023).","journal-title":"Exp. Mol. Med."},{"key":"51967_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41419-024-06691-w","volume":"15","author":"QY Zhou","year":"2024","unstructured":"Zhou, Q. Y. et al. The crosstalk between mitochondrial quality control and metal-dependent cell death. Cell. Death Dis. 15, 299. https:\/\/doi.org\/10.1038\/s41419-024-06691-w (2024).","journal-title":"Cell. Death Dis."},{"key":"51967_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00262-025-03967-8","volume":"74","author":"G Cheng","year":"2025","unstructured":"Cheng, G. et al. Machine learning-derived prognostic signature integrating programmed cell death and mitochondrial function in renal clear cell carcinoma: identification of PIF1 as a novel target. Cancer Immunol. Immunother. 74, 113. https:\/\/doi.org\/10.1007\/s00262-025-03967-8 (2025).","journal-title":"Cancer Immunol. Immunother"},{"key":"51967_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11684-024-1093-3","volume":"19","author":"X Shi","year":"2025","unstructured":"Shi, X., Han, S., Wang, G. & Zhou, G. Mitochondrial-associated programmed-cell-death patterns for predicting the prognosis of non-small-cell lung cancer. Front. Med. 19, 101\u2013120. https:\/\/doi.org\/10.1007\/s11684-024-1093-3 (2025).","journal-title":"Front. Med."},{"key":"51967_CR32","doi-asserted-by":"publisher","unstructured":"Wang, L., Zhao, Z., Shu, K. & Ma, M. MPCD index for hepatocellular carcinoma patients based on mitochondrial function and cell death patterns. Int. J. Mol. Sci. 26 https:\/\/doi.org\/10.3390\/ijms26010118 (2024).","DOI":"10.3390\/ijms26010118"},{"key":"51967_CR33","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1016\/j.apsb.2022.04.005","volume":"12","author":"M Tang","year":"2022","unstructured":"Tang, M. et al. A mitochondria-targeting lipid-small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model. Acta Pharm. Sin B. 12, 2672\u20132682. https:\/\/doi.org\/10.1016\/j.apsb.2022.04.005 (2022).","journal-title":"Acta Pharm. Sin B"},{"key":"51967_CR34","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1038\/s41467-020-17254-w","volume":"11","author":"JA Bennett","year":"2020","unstructured":"Bennett, J. A. et al. The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function. Nat. Commun. 11, 3479. https:\/\/doi.org\/10.1038\/s41467-020-17254-w (2020).","journal-title":"Nat. Commun."},{"key":"51967_CR35","doi-asserted-by":"publisher","unstructured":"Murphy, S. J. et al. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor. Gastroenterology 145, 1098\u20131109 e1091. https:\/\/doi.org\/10.1053\/j.gastro.2013.07.049 (2013).","DOI":"10.1053\/j.gastro.2013.07.049"},{"key":"51967_CR36","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri, M. et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 7, 100336. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100336 (2022).","journal-title":"ESMO Open."},{"key":"51967_CR37","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1158\/1078-0432.CCR-23-0825","volume":"29","author":"SG Kisling","year":"2023","unstructured":"Kisling, S. G. et al. A novel HOXA10-associated 5-gene-based prognostic signature for stratification of short-term survivors of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 29, 3759\u20133770. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0825 (2023).","journal-title":"Clin. Cancer Res."},{"key":"51967_CR38","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1158\/0008-5472.CAN-24-0585","volume":"84","author":"L May","year":"2024","unstructured":"May, L. et al. The Innate Immune System and the TRAIL-Bcl-XL axis mediate a sex bias in lung cancer and confer a therapeutic vulnerability in females. Cancer Res. 84, 4140\u20134155. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0585 (2024).","journal-title":"Cancer Res."},{"key":"51967_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc.2017.28","volume":"17","author":"S von Karstedt","year":"2017","unstructured":"von Karstedt, S., Montinaro, A. & Walczak, H. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nat. Rev. Cancer. 17, 352\u2013366. https:\/\/doi.org\/10.1038\/nrc.2017.28 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"51967_CR40","doi-asserted-by":"publisher","first-page":"714365","DOI":"10.3389\/fphar.2021.714365","volume":"12","author":"F Cai","year":"2021","unstructured":"Cai, F. et al. AK2 promotes the migration and invasion of lung adenocarcinoma by activating TGF-beta\/Smad pathway in vitro and in vivo. Front. Pharmacol. 12, 714365. https:\/\/doi.org\/10.3389\/fphar.2021.714365 (2021).","journal-title":"Front. Pharmacol."},{"key":"51967_CR41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41419-022-04921-7","volume":"13","author":"H Kim","year":"2022","unstructured":"Kim, H. et al. AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis. Cell. Death Dis. 13, 469. https:\/\/doi.org\/10.1038\/s41419-022-04921-7 (2022).","journal-title":"Cell. Death Dis."},{"key":"51967_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-025-11204-1","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. MRPL15 as a key gene in the malignant proliferation of LUAD. Biochem. Genet. https:\/\/doi.org\/10.1007\/s10528-025-11204-1 (2025).","journal-title":"Biochem. Genet."},{"key":"51967_CR43","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/cam4.3907","volume":"10","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer. Cancer Med. 10, 3655\u20133673. https:\/\/doi.org\/10.1002\/cam4.3907 (2021).","journal-title":"Cancer Med."},{"key":"51967_CR44","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12094-023-03269-4","volume":"26","author":"JW Zhao","year":"2024","unstructured":"Zhao, J. W. et al. The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity. Clin. Transl Oncol. 26, 496\u2013514. https:\/\/doi.org\/10.1007\/s12094-023-03269-4 (2024).","journal-title":"Clin. Transl Oncol."},{"key":"51967_CR45","doi-asserted-by":"publisher","first-page":"102560","DOI":"10.1016\/j.tranon.2025.102560","volume":"62","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. The oncogenic role of BMAL2 in non-small cell lung cancer: MRPL15-mediated regulation of apoptosis and ferroptosis. Transl Oncol. 62, 102560. https:\/\/doi.org\/10.1016\/j.tranon.2025.102560 (2025).","journal-title":"Transl Oncol."},{"key":"51967_CR46","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-025-07781-z","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. SLC44A2 negatively regulates mitochondrial fatty acid oxidation to suppress colorectal progression by blocking the MUL1-CPT2 interaction. Cell. Death Dis. 16, 468. https:\/\/doi.org\/10.1038\/s41419-025-07781-z (2025).","journal-title":"Cell. Death Dis."},{"key":"51967_CR47","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41594-024-01309-3","volume":"31","author":"J He","year":"2024","unstructured":"He, J. et al. RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth. Nat. Struct. Mol. Biol. 31, 1413\u20131425. https:\/\/doi.org\/10.1038\/s41594-024-01309-3 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"51967_CR48","doi-asserted-by":"publisher","first-page":"101527","DOI":"10.1016\/j.lanwpc.2025.101527","volume":"57","author":"S Sanjida","year":"2025","unstructured":"Sanjida, S. et al. Prevalence of surgery in Indigenous people with cancer: a systematic review and meta-analysis. Lancet Reg. Health West. Pac. 57, 101527. https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101527 (2025).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"51967_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4062\/biomolther.2019.097","volume":"28","author":"I Saiki","year":"2020","unstructured":"Saiki, I., Yara, M., Yamanaka, T., Uchino, H. & Inazu, M. Functional expression of choline transporter-like protein 1 in LNCaP prostate cancer cells: a novel molecular target. Biomol. Ther. (Seoul). 28, 195\u2013201. https:\/\/doi.org\/10.4062\/biomolther.2019.097 (2020).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"51967_CR50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4062\/biomolther.2017.113","volume":"26","author":"F Nagashima","year":"2018","unstructured":"Nagashima, F. et al. Molecular and functional characterization of choline transporter-like proteins in esophageal cancer cells and potential therapeutic targets. Biomol. Ther. (Seoul). 26, 399\u2013408. https:\/\/doi.org\/10.4062\/biomolther.2017.113 (2018).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"51967_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jphs.2016.04.022","volume":"131","author":"R Nishiyama","year":"2016","unstructured":"Nishiyama, R. et al. Identification and functional analysis of choline transporter in tongue cancer: a novel molecular target for tongue cancer therapy. J. Pharmacol. Sci. 131, 101\u2013109. https:\/\/doi.org\/10.1016\/j.jphs.2016.04.022 (2016).","journal-title":"J. Pharmacol. Sci."},{"key":"51967_CR52","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/jjco\/hyac074","volume":"52","author":"Y Wada","year":"2022","unstructured":"Wada, Y. et al. Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer. Jpn J. Clin. Oncol. 52, 887\u2013895. https:\/\/doi.org\/10.1093\/jjco\/hyac074 (2022).","journal-title":"Jpn J. Clin. Oncol."},{"key":"51967_CR53","doi-asserted-by":"publisher","unstructured":"Hirai, K. et al. Molecular and functional analysis of choline transporters and antitumor effects of choline transporter-like protein 1 inhibitors in human pancreatic cancer cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21155190 (2020).","DOI":"10.3390\/ijms21155190"},{"key":"51967_CR54","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3892\/etm.2025.12892","volume":"30","author":"S Gong","year":"2025","unstructured":"Gong, S., Yang, J., Pan, C., Peng, F. & Pan, C. Analysis of a pan-cancer panel reveals the amino acid metabolism-related gene MTHFD1 as a potential prognostic and immunotherapeutic biomarker. Exp. Ther. Med. 30, 142. https:\/\/doi.org\/10.3892\/etm.2025.12892 (2025).","journal-title":"Exp. Ther. Med."},{"key":"51967_CR55","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s42255-023-00771-5","volume":"5","author":"AC Green","year":"2023","unstructured":"Green, A. C. et al. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nat. Metab. 5, 642\u2013659. https:\/\/doi.org\/10.1038\/s42255-023-00771-5 (2023).","journal-title":"Nat. Metab."},{"key":"51967_CR56","doi-asserted-by":"publisher","first-page":"e70267","DOI":"10.1002\/cam4.70267","volume":"13","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. MTHFD1 regulates autophagy to promote growth and metastasis in colorectal cancer via the PI3K-AKT-mTOR signaling pathway. Cancer Med. 13, e70267. https:\/\/doi.org\/10.1002\/cam4.70267 (2024).","journal-title":"Cancer Med."},{"key":"51967_CR57","doi-asserted-by":"publisher","first-page":"112666","DOI":"10.1016\/j.celrep.2023.112666","volume":"42","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y. et al. Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression. Cell. Rep. 42, 112666. https:\/\/doi.org\/10.1016\/j.celrep.2023.112666 (2023).","journal-title":"Cell. Rep."},{"key":"51967_CR58","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/jcmm.14831","volume":"24","author":"Z Cheng","year":"2020","unstructured":"Cheng, Z. et al. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia. J. Cell. Mol. Med. 24, 1067\u20131075. https:\/\/doi.org\/10.1111\/jcmm.14831 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"51967_CR59","doi-asserted-by":"publisher","first-page":"36850421997273","DOI":"10.1177\/0036850421997273","volume":"104","author":"F Ding","year":"2021","unstructured":"Ding, F. et al. A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation. Sci. Prog. 104, 36850421997273. https:\/\/doi.org\/10.1177\/0036850421997273 (2021).","journal-title":"Sci. Prog"},{"key":"51967_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40880-018-0315-y","volume":"38","author":"F Du","year":"2018","unstructured":"Du, F. et al. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun. (Lond). 38, 45. https:\/\/doi.org\/10.1186\/s40880-018-0315-y (2018).","journal-title":"Cancer Commun. (Lond)"},{"key":"51967_CR61","doi-asserted-by":"publisher","first-page":"19403","DOI":"10.1038\/s41598-023-46484-3","volume":"13","author":"F Tajik","year":"2023","unstructured":"Tajik, F. et al. Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors. Sci. Rep. 13, 19403. https:\/\/doi.org\/10.1038\/s41598-023-46484-3 (2023).","journal-title":"Sci. Rep."},{"key":"51967_CR62","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1186\/s12967-024-06003-y","volume":"22","author":"T Tian","year":"2024","unstructured":"Tian, T. et al. YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1\/2 and JNK phosphorylation in the MAPK pathway. J. Transl Med. 22, 1159. https:\/\/doi.org\/10.1186\/s12967-024-06003-y (2024).","journal-title":"J. Transl Med."},{"key":"51967_CR63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12032-024-02349-x","volume":"41","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt\/beta-catenin signaling axis. Med. Oncol. 41, 100. https:\/\/doi.org\/10.1007\/s12032-024-02349-x (2024).","journal-title":"Med. Oncol."},{"key":"51967_CR64","doi-asserted-by":"publisher","first-page":"e2301714","DOI":"10.1002\/advs.202301714","volume":"10","author":"JXT Lee","year":"2023","unstructured":"Lee, J. X. T. et al. YWHAG deficiency disrupts the EMT-associated network to induce oxidative cell death and prevent metastasis. Adv. Sci. (Weinh). 10, e2301714. https:\/\/doi.org\/10.1002\/advs.202301714 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"51967_CR65","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-023-04033-6","volume":"21","author":"J Chang","year":"2023","unstructured":"Chang, J. et al. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. J. Transl Med. 21, 191. https:\/\/doi.org\/10.1186\/s12967-023-04033-6 (2023).","journal-title":"J. Transl Med."},{"key":"51967_CR66","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"51967_CR67","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"51967_CR68","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6 (2022).","journal-title":"Nat. Commun."},{"key":"51967_CR69","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1186\/s12885-024-13203-8","volume":"24","author":"K Sato","year":"2024","unstructured":"Sato, K. et al. Time-dependent personalized prognostic analysis by machine learning in biochemical recurrence after radical prostatectomy: a retrospective cohort study. BMC Cancer. 24, 1446. https:\/\/doi.org\/10.1186\/s12885-024-13203-8 (2024).","journal-title":"BMC Cancer"},{"key":"51967_CR70","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51967-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51967-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:41:41Z","timestamp":1783384901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51967-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51967"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51967-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were approved by Ethics Committee of JingZhou hospital affiliated to Yangtze University (Ethics Approval No.: 2015-188-01). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declarations"}}],"article-number":"20966"}}